ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04724	Glutamatergic synapse	36/421	152/7206	1.84124167314e-13
ko04744	Phototransduction	17/421	36/7206	2.41324139301e-12
ko04727	GABAergic synapse	29/421	110/7206	2.53965140188e-12
ko04728	Dopaminergic synapse	38/421	185/7206	4.43403291502e-12
ko04721	Synaptic vesicle cycle	23/421	80/7206	7.30799541462e-11
ko04725	Cholinergic synapse	33/421	160/7206	1.08632623766e-10
ko05033	Nicotine addiction	16/421	56/7206	6.63969143495e-08
ko04723	Retrograde endocannabinoid signaling	30/421	175/7206	7.21514413096e-08
ko04911	Insulin secretion	23/421	117/7206	2.00173871547e-07
ko04713	Circadian entrainment	25/421	136/7206	2.30105280275e-07
ko05032	Morphine addiction	22/421	110/7206	2.69813744708e-07
ko04726	Serotonergic synapse	24/421	137/7206	1.00816747438e-06
ko04360	Axon guidance	32/421	233/7206	5.13846867888e-06
ko04024	cAMP signaling pathway	34/421	279/7206	3.74758591455e-05
ko04514	Cell adhesion molecules (CAMs)	20/421	130/7206	5.7866923625e-05
ko05203	Viral carcinogenesis	3/421	277/7206	0.000109748950266
ko04964	Proximal tubule bicarbonate reclamation	8/421	29/7206	0.000183427067915
ko04261	Adrenergic signaling in cardiomyocytes	25/421	205/7206	0.000398049125133
ko04071	Sphingolipid signaling pathway	21/421	162/7206	0.000503164138227
ko04010	MAPK signaling pathway	33/421	321/7206	0.00137000528626
ko04720	Long-term potentiation	14/421	99/7206	0.00171608384563
ko04961	Endocrine and other factor-regulated calcium reabsorption	10/421	59/7206	0.00197863512056
ko04960	Aldosterone-regulated sodium reabsorption	8/421	41/7206	0.00220242647754
ko05031	Amphetamine addiction	13/421	91/7206	0.00226213955263
ko05322	Systemic lupus erythematosus	1/421	151/7206	0.00228098065614
ko05030	Cocaine addiction	11/421	73/7206	0.0031626452098
ko04970	Salivary secretion	13/421	95/7206	0.00333113694
ko03040	Spliceosome	1/421	145/7206	0.00337505643259
ko05014	Amyotrophic lateral sclerosis (ALS)	11/421	74/7206	0.00352523960601
ko04020	Calcium signaling pathway	27/421	265/7206	0.0045655233299
ko04730	Long-term depression	11/421	78/7206	0.00532165885012
ko04745	Phototransduction - fly	7/421	38/7206	0.00575652353912
ko04972	Pancreatic secretion	14/421	111/7206	0.00620392642917
ko04740	Olfactory transduction	11/421	80/7206	0.00645708334785
ko04925	Aldosterone synthesis and secretion	13/421	105/7206	0.00957311625185
ko05168	Herpes simplex infection	3/421	182/7206	0.00961177067591
ko04973	Carbohydrate digestion and absorption	7/421	42/7206	0.0100690296856
ko05142	Chagas disease (American trypanosomiasis)	15/421	130/7206	0.0119806279855
ko04930	Type II diabetes mellitus	8/421	54/7206	0.0123711187821
ko04144	Endocytosis	31/421	342/7206	0.0128158937834
ko04072	Phospholipase D signaling pathway	20/421	197/7206	0.0133226218721
ko04971	Gastric acid secretion	12/421	98/7206	0.0139964278513
ko04070	Phosphatidylinositol signaling system	13/421	112/7206	0.0143486745676
ko04918	Thyroid hormone synthesis	11/421	86/7206	0.0164959641009
ko03013	RNA transport	3/421	166/7206	0.0184333888192
ko05164	Influenza A	3/421	167/7206	0.0184704292697
ko04060	Cytokine-cytokine receptor interaction	4/421	191/7206	0.0187136470162
ko04062	Chemokine signaling pathway	20/421	201/7206	0.0204512882407
ko00240	Pyrimidine metabolism	1/421	110/7206	0.0214954784511
ko04120	Ubiquitin mediated proteolysis	2/421	138/7206	0.0252255136416
ko04976	Bile secretion	10/421	80/7206	0.0253425398153
ko04080	Neuroactive ligand-receptor interaction	35/421	423/7206	0.0323975671207
ko05169	Epstein-Barr virus infection	5/421	206/7206	0.0333263784978
ko05205	Proteoglycans in cancer	8/421	271/7206	0.0345184552717
ko04130	SNARE interactions in vesicular transport	6/421	44/7206	0.041209430209
ko00604	Glycosphingolipid biosynthesis - ganglio series	3/421	14/7206	0.0445288714375
ko05010	Alzheimer's disease	19/421	202/7206	0.0455526127184
ko04110	Cell cycle	3/421	145/7206	0.0480475886598